Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × Metformin × Clear all

Status

Sponsor Class

Study Type

Interventional 12 Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3 Pancreatic Neoplasms 2 Diabetes Mellitus, Type 2 2 Breast Neoplasms 2 Sleep Wake Disorders 1 Rectal Neoplasms 1 Neoplasms 1 Lymphatic Metastasis 1 Fatigue 1 Depression 1 Communicable Diseases 1

Interventions

Surveys and Questionnaires 71 Blood Specimen Collection 45 Interviews as Topic 24 Data Collection 15 Radiotherapy 12 Observation 11 Magnetic Resonance Spectroscopy 11 Exercise 11 Watchful Waiting 9 Hematologic Tests 9 Drug Therapy 9 Quality of Life 8 Therapeutics 6 Specimen Handling 6 Focus Groups 6 Biopsy 6 Phlebotomy 5 Magnetic Resonance Imaging 5 Lapatinib 5 pembrolizumab 4 Trastuzumab 4 Standard of Care 4 Restraint, Physical 4 Palliative Care 4 Nivolumab 4 Neoadjuvant Therapy 4 Mental Status and Dementia Tests 4 Ipilimumab 4 High-Throughput Nucleotide Sequencing 4 Base Sequence 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01195259 2013-10-28

Malignancy Meta Analysis for BRL49653

GlaxoSmithKline

Diabetes Mellitus, Type 2, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡